M. A. Madwar

497 total citations
11 papers, 346 citations indexed

About

M. A. Madwar is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, M. A. Madwar has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in M. A. Madwar's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). M. A. Madwar is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). M. A. Madwar collaborates with scholars based in Egypt, Germany and United States. M. A. Madwar's co-authors include J. Rasenack, Sanaa M. Kamal, A. Voller, Thomas Peters, Leonardo Bianchi, Jason Chen, J Fehr, Nezam H. Afdhal, Khalifa Khalifa and Camilla S. Graham and has published in prestigious journals such as Hepatology, Journal of Virology and Journal of Clinical Virology.

In The Last Decade

M. A. Madwar

10 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. A. Madwar Egypt	7	273	225	64	33	27	11	346
Pierre Berthelot France	9	250 0.9×	272 1.2×	98 1.5×	60 1.8×	15 0.6×	10	447
Niveen Saudy Egypt	10	219 0.8×	264 1.2×	85 1.3×	40 1.2×	28 1.0×	21	398
Abeer Elkady Japan	15	359 1.3×	347 1.5×	22 0.3×	42 1.3×	20 0.7×	18	479
Kátia Luz Torres Brazil	10	104 0.4×	199 0.9×	39 0.6×	44 1.3×	24 0.9×	27	322
Tonya Hayden United States	8	198 0.7×	172 0.8×	24 0.4×	42 1.3×	16 0.6×	12	327
Tomokuni Nakayoshi Japan	5	344 1.3×	358 1.6×	16 0.3×	38 1.2×	13 0.5×	7	402
M. Raptopoulou‐Gigi Greece	12	521 1.9×	582 2.6×	15 0.2×	25 0.8×	60 2.2×	37	704
R. Hammond Australia	10	216 0.8×	263 1.2×	15 0.2×	145 4.4×	22 0.8×	20	383
Izabela Voieta Brazil	13	113 0.4×	61 0.3×	225 3.5×	72 2.2×	19 0.7×	27	340
Małgorzata Wiśniewska‐Ligier Poland	11	31 0.1×	193 0.9×	65 1.0×	71 2.2×	88 3.3×	27	309

Countries citing papers authored by M. A. Madwar

Since Specialization

Citations

This map shows the geographic impact of M. A. Madwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Madwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Madwar more than expected).

Fields of papers citing papers by M. A. Madwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Madwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Madwar. The network helps show where M. A. Madwar may publish in the future.

Co-authorship network of co-authors of M. A. Madwar

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Madwar. A scholar is included among the top collaborators of M. A. Madwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Madwar. M. A. Madwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Kamal, Sanaa M., Jason Chen, J Fehr, et al.. (2006). Duration of peginterferon therapy in acute hepatitis C: A randomized trial. Hepatology. 43(5). 923–931. 97 indexed citations

2.

Elwakil, Reda, et al.. (2006). P.260 Peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive Egyptian patients. Journal of Clinical Virology. 36. S142–S143. 2 indexed citations

3.

Kamal, Sanaa M., M. A. Madwar, Camilla S. Graham, et al.. (2004). Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients. Journal of Virology. 78(22). 12252–12258. 67 indexed citations

4.

Zekri, Abdel‐Rahman N., et al.. (2001). Hepatitis C Virus Genotyping versus Serotyping in Egyptian Patients. Infection. 29(1). 24–26. 20 indexed citations

5.

Kamal, Sanaa M., et al.. (2000). Clinical, virological and histopathological features: long‐term follow‐up in patients with chronic hepatitis C co‐infected with S. mansoni. Liver International. 20(4). 281–289. 99 indexed citations

6.

Madwar, M. A., et al.. (1999). Hepatitis C virus transmission in family members of Egyptian patients with HCV related chronic liver disease.. PubMed. 74(3-4). 313–32. 13 indexed citations

7.

Madwar, M. A., et al.. (1998). Study of the significance of percentage of peripheral CD4+ & CD8+ T cells and the hepatitis C virus genotypes in Egyptian patients with chronic hepatitis C.. PubMed. 73(1-2). 41–55. 2 indexed citations

8.

Madwar, M. A., et al.. (1990). Correlation between intensity of infection and hepatic histopathological lesions in bilharzial patients.. PubMed. 20(1). 147–50. 1 indexed citations

9.

Madwar, M. A., et al.. (1978). Complement components and immunoglobulins in patients with schistosomiasis.. PubMed. 34(3). 354–8. 6 indexed citations

10.

Madwar, M. A. & A. Voller. (1975). Circulating soluble antigens and antibody in schistosomiasis.. BMJ. 1(5955). 435–436. 39 indexed citations

11.

Mousa, Aya, et al.. (1967). Experimental bilharzial lesions in the lungs of non-susceptible animals.. PubMed. 50(11). 611–25.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact